Epiploic appendagitis is a relatively rare, benign condition of the colon that can be easily misdiagnosed due to its vague symptoms. It is caused by inflammation of the epiploic appendages, small fatty appendages that are attached to the outer wall of the colon. The condition is often misdiagnosed as diverticulitis, appendicitis, or even colorectal cancer. It is important for doctors to be aware of the condition in order to properly diagnose and treat it.
The most common symptom of epiploic appendagitis is abdominal pain, which is usually localized to the left lower quadrant. Other symptoms can include nausea, vomiting, constipation, and fever. The pain is usually sharp and can radiate to the back or groin area. It can also be worse when the patient is lying down or when they press on the area.
The diagnosis of epiploic appendagitis is usually made through a combination of physical examination, imaging tests, and laboratory tests. Physical examination often reveals tenderness to palpation in the left lower quadrant. Imaging tests such as CT scans, MRIs, and ultrasounds can help to confirm the diagnosis by showing the presence of inflamed epiploic appendages. Laboratory tests, such as blood tests, can be used to rule out other conditions.
The treatment of epiploic appendagitis is usually conservative. Treatment typically involves bed rest, pain medications, and antibiotics. Surgery is rarely necessary, although it may be recommended if the condition does not respond to conservative treatments. In most cases, the condition resolves on its own within a few weeks.
Although epiploic appendagitis is usually a benign condition, there are some potential complications that can occur. These include abscess formation, perforation of the colon, and obstruction of the colon. It is important for doctors to be aware of these potential complications in order to provide the best possible care for their patients.
Epiploic appendagitis is a relatively rare condition of the colon that can be easily misdiagnosed due to its vague symptoms. It is important for doctors to be aware of the condition in order to properly diagnose and treat it. Treatment is usually conservative and involves bed rest, pain medications, and antibiotics. Surgery is rarely necessary, although it may be recommended if the condition does not respond to conservative treatments. In most cases, the condition resolves on its own within a few weeks. However, it is important for doctors to be aware of the potential complications that can occur in order to provide the best possible care for their patients.
1.
A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.
2.
The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.
5.
A garden can save your life
1.
Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy
2.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
3.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
4.
Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care
5.
Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation